139 related articles for article (PubMed ID: 8509438)
1. Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
Klän R; Knispel HH; Meier T
J Cancer Res Clin Oncol; 1993; 119(8):482-5. PubMed ID: 8509438
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of N-n-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in rats by administration of disulfiram in the diet.
Irving CC; Tice AJ; Murphy WM
Cancer Res; 1979 Aug; 39(8):3040-3. PubMed ID: 455288
[TBL] [Abstract][Full Text] [Related]
3. Influence of disulfiram on the metabolism of the urinary bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
Irving CC; Daniel DS
Carcinogenesis; 1987 Sep; 8(9):1309-15. PubMed ID: 3113755
[TBL] [Abstract][Full Text] [Related]
4. Effect of fleroxacin on mouse bladder carcinogenesis with N-butyl-N- (4-hydroxybutyl) nitrosamine.
Ebisuno S; Nishikawa T; Kohjimoto Y; Nishihata M; Inagaki T; Watanabe T; Ohkawa T
Urol Int; 1999; 62(3):150-4. PubMed ID: 10529665
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of 2-mercaptoethane sulfonate and 6-phenylhexyl isothiocyanate on urinary bladder tumorigenesis in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nishikawa A; Morse MA; Chung FL
Cancer Lett; 2003 Apr; 193(1):11-6. PubMed ID: 12691818
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
7. Suppression of rat urinary bladder carcinogenesis by alpha-difluoromethylornithine.
Homma Y; Kakizoe T; Samma S; Oyasu R
J Urol; 1989 Jun; 141(6):1454-7. PubMed ID: 2498534
[TBL] [Abstract][Full Text] [Related]
8. Strain differences in mice with invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Ohtani M; Kakizoe T; Sato S; Sugimura T; Fukushima S
J Cancer Res Clin Oncol; 1986; 112(2):107-10. PubMed ID: 3771618
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by alpha-difluoromethylornithine.
Homma Y; Kakizoe T; Samma S; Oyasu R
Cancer Res; 1987 Dec; 47(23):6176-9. PubMed ID: 3119193
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of urinary bladder tumorigenesis by carcinogen-exposed stroma.
Uchida K; Samma S; Momose H; Kashihara N; Rademaker A; Oyasu R
J Urol; 1990 Mar; 143(3):618-21. PubMed ID: 2304182
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
13. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Suzuki E; Mochizuki M; Okada M
Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
[TBL] [Abstract][Full Text] [Related]
14. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
[TBL] [Abstract][Full Text] [Related]
15. Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder.
Hirose M; Fukushima S; Sakata T; Inui M; Ito N
Cancer Lett; 1983 Nov; 21(1):23-7. PubMed ID: 6640511
[TBL] [Abstract][Full Text] [Related]
16. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Rao KV; Detrisac CJ; Steele VE; Hawk ET; Kelloff GJ; McCormick DL
Carcinogenesis; 1996 Jul; 17(7):1435-8. PubMed ID: 8706245
[TBL] [Abstract][Full Text] [Related]
17. Analyses of avidin-biotin complexes with lectins of membrane glycoproteins in the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Takai K; Kakizoe T; Sekine T; Sato S; Niijima T
J Urol; 1987 Jan; 137(1):136-9. PubMed ID: 2432280
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Balakrishnan D; Sundaresan S
Hum Exp Toxicol; 2016 Jun; 35(6):685-92. PubMed ID: 26251508
[TBL] [Abstract][Full Text] [Related]
19. Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves.
Sato D; Matsushima M
Int J Urol; 2003 Mar; 10(3):160-6. PubMed ID: 12622713
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
